BERLIN—Bayer AG on Tuesday posted a loss in the third quarter as the coronavirus pandemic compounded problems the German chemical and drug giant has been facing since its acquisition of agriculture giant Monsanto just over two years ago.
Bayer also said it would need an extra $750,000 on top of a settlement worth up to $10.9 billion it announced over the summer to resolve a legal battle with U.S. plaintiffs alleging the Roundup weedkillers inherited from Monsanto cause cancer. Bayer has consistently denied that Roundup or…
